EIF2AK3 and breast carcinoma: Notably, the concentration of neratinib required to downregulate pERK expression was significantly higher for SMBO-170, SCBO-8, SMBO-109, SMBO-114, and SMBO-106 urothelial cancer organoids than BT-474 breast cancer cells.